Improving the Identification of High Risk Precursor B Acute Lymphoblastic Leukemia Patients with Earlier Quantification of Minimal Residual Disease

The stratification of patients with acute lymphoblastic leukemia (ALL) into treatment risk groups based on quantification of minimal residual disease (MRD) after induction therapy is now well accepted but the relapse rate of about 20% in intermediate risk patients remains a challenge. The purpose of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Karsa, Mawar, Dalla Pozza, Luciano, Venn, Nicola C., Law, Tamara, Shi, Rachael, Giles, Jodie E., Bahar, Anita Y., Cross, Shamira, Catchpoole, Daniel, Haber, Michelle, Marshall, Glenn M., Norris, Murray D., Sutton, Rosemary
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2013
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3795712/
https://ncbi.nlm.nih.gov/pubmed/24146872
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0076455
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados